Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04022915 · ClinicalTrials.gov registry record · Phase 1

PET Fibrin Imaging of DVT and PE

A Phase 1 study, sponsored by Peter Caravan.

Terminated
Registry status
Phase 1
Development phase
6
Enrollment target

NCT04022915: Clinical Trial Phase 1 study, sponsored by Peter Caravan.

NCT04022915 is a Phase 1 study that was terminated before completion, run by Peter Caravan. The registered enrollment target is 6 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04022915, a Phase 1 study, was terminated before completion, sponsored by Peter Caravan.

TERMINATED
Registry status
Phase 1
Development phase
6 participants
Enrollment target

Study Summary

This study aims to investigate a novel positron emission tomography(PET)-probe for imaging of fresh intravascular blood clots in pulmonary embolism (PE) and deep venous thrombosis (DVT).

Primary Outcome

To determine the location of the thrombus regions of interest (ROIs) within the lungs using PET-CT imaging in comparison to the ROI of filling defects on CT-angiogram.

Interventions

  • DRUG 64Cu-FBP8
  • DIAGNOSTIC_TEST PET-CT imaging

Trial Details

FieldValue
Enrollment Target 6 participants
Start Date 2019-05-13
Est. Completion 2024-08-26
Phase Phase 1
Peter Caravan

3 total trials

Why NCT04022915 stopped before completion

NCT04022915 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (90% lower).

The record links to 0 conditions, and to 2 interventions - of which 64Cu-FBP8 is the first listed.

NCT04022915 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04022915 about?

NCT04022915 is a clinical study titled "PET Fibrin Imaging of DVT and PE". This study aims to investigate a novel positron emission tomography(PET)-probe for imaging of fresh intravascular blood clots in pulmonary embolism (PE) and deep venous thrombosis (DVT).

What is the current status of trial NCT04022915?

This trial is currently terminated. It is a Phase 1 study. The enrollment target is 6 participants. The study started on 2019-05-13. Estimated completion is 2024-08-26.

What interventions are being tested in trial NCT04022915?

The interventions under investigation include: 64Cu-FBP8 (DRUG), PET-CT imaging (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT04022915?

This trial is sponsored by Peter Caravan, which has 3 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04022915's enrollment target sits among peer trials

6 1974th of 2000 higher than 12 of 2,000 other Phase 1 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04022915, the US trial registry maintained by the National Library of Medicine. NCT04022915 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.